Abstract:The quiescence and activation of adult stem cells are regulated by many kinds of molecular mechanisms, and RNA alternative splicing participates in regulating many cellular processes. However, the relationship between stem cell quiescence and activation regulation and gene alternative splicing has yet to be studied. In this study, we aimed to elucidate the regulation of stem cell quiescence and activation by RNA alternative splicing. The upregulated genes in activated mouse neural stem cells (NSCs), muscle stem cells, and hematopoietic stem cells were collected for Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis. The genes from three tissue stem cells underwent Venn analysis. The mouse NSCs were used for quiescence and reactivation induction. The immunostaining of cell-specific markers was performed to identify cell properties. The reverse transcription-polymerase chain reaction and western blotting were used to detect the gene expression and protein expression, respectively. We found that the upregulated genes in activated stem cells from three tissues were all enriched in RNA splicing-related biological processes; the upregulated RNA splicing-related genes in activated stem cells displayed tissue differences; mouse NSCs were successfully induced into quiescence and reactivation in vitro without losing differentiation potential; serine and arginine-rich splicing factor 3 (Srsf3) was highly expressed in the activated mouse NSCs, and the overexpression of SRSF3 protein promoted the activation of quiescent mouse NSCs and increased the neural cell production. Our data indicate that the alternative splicing change may underline the transition of quiescence and activation of stem cells. The manipulation of the splicing factor may benefit tissue repair by promoting the activation of quiescent stem cells.

Serine and Arginine Rich Splicing Factor 1: a Potential Target for Neuroprotection and Other Diseases

Targeting Serine- and Arginine-Rich Splicing Factors to Rectify Aberrant Alternative Splicing.

Towards Understandings of Serine/arginine-Rich Splicing Factors

Molecular interactions connecting the function of the serine-arginine-rich protein SRSF1 to protein phosphatase 1

A Critical Update on the Strategies Towards Small Molecule Inhibitors Targeting Serine/arginine-rich (SR) Proteins and Serine/arginine-rich Proteins Related Kinases in Alternative Splicing

Targeting splicing factors for cancer therapy

Oncogenic SRSF3 in Health and Diseases.

Controlled by disorder: phosphorylation modulates SRSF1 domain availability for spliceosome maturation

SR Splicing Factors Promote Cancer Via Multiple Regulatory Mechanisms.

Serine and Arginine-Rich Splicing Factor 3 Promotes the Activation of Quiescent Mouse Neural Stem Cells.

Therapeutic potential of alternative splicing in cardiovascular diseases

Targeting Splicing Factor SRSF6 for Cancer Therapy

SR proteins in cancer: function, regulation, and small inhibitor

Targeting RNA-Splicing for SMA Treatment

Identification of SRSF10 As a Regulator of SMN2 ISS-N1.

Splicing factors: Insights into their regulatory network in alternative splicing in cancer

Mechanisms of Neuronal Alternative Splicing and Strategies for Therapeutic Interventions

Plant Serine/arginine-Rich Proteins: Versatile Players in RNA Processing

Splicing Factor SRSF2-centric Gene Regulation

Emerging Roles of SRSF3 As a Therapeutic Target for Cancer

Alternative Splicing As a Biomarker and Potential Target for Drug Discovery